Journal article
Prospective randomized trial of sclerotherapy vs standard treatment for epistaxis due to hereditary hemorrhagic telangiectasia
International forum of allergy & rhinology, Vol.5(5), pp.435-440
05/2015
DOI: 10.1002/alr.21484
PMCID: PMC4756906
PMID: 25643928
Abstract
Background
Our previous studies have demonstrated the tolerability and low side-effect profile of office-based sclerotherapy with sodium tetradecyl sulfate (STS) for treating recurrent epistaxis due to hereditary hemorrhagic telangiectasia (HHT). The objective of this study was to use a prospective randomized trial to determine the effectiveness of sclerotherapy with STS vs standard treatment.
Methods
This prospective randomized trial (conducted from November 1, 2011, through January 31, 2014) involved 17 patients with recurrent epistaxis due to HHT. We defined standard treatment as continuation of any treatment that the patient had previously undergone, such as moisturization, packing, and cautery. We used a crossover design, so study participants were randomized to either sclerotherapy or standard treatment during the first time period, and then to the other during the second period. The primary outcome measure was frequency and severity of epistaxis, as measured by the epistaxis severity score (ESS). The ESS is a 10-point scale, with higher scores corresponding to more bleeding.
Results
After controlling for treatment order, bleeding was substantially better controlled after sclerotherapy; the ESS after sclerotherapy was nearly one point lower than after standard treatment (−0.95, 1-sided p = 0.027). Treatment order, baseline ESS, the number of lesions, moisturization practices, and a history of previous blood transfusions did not significantly affect the results.
Conclusion
This trial demonstrated that sclerotherapy with STS (vs standard treatment) significantly reduced epistaxis due to HHT.
Details
- Title: Subtitle
- Prospective randomized trial of sclerotherapy vs standard treatment for epistaxis due to hereditary hemorrhagic telangiectasia
- Creators
- Holly Boyer - University of Minnesota Medical SchoolPatricia Fernandes - University of Minnesota Medical SchoolChap Le - University of MinnesotaBevan Yueh - University of Minnesota Medical School
- Resource Type
- Journal article
- Publication Details
- International forum of allergy & rhinology, Vol.5(5), pp.435-440
- DOI
- 10.1002/alr.21484
- PMID
- 25643928
- PMCID
- PMC4756906
- NLM abbreviation
- Int Forum Allergy Rhinol
- ISSN
- 2042-6976
- eISSN
- 2042-6984
- Number of pages
- 6
- Grant note
- P30CA077598 / National Cancer Institute (http://data.elsevier.com/vocabulary/SciValFunders/100000054)
- Language
- English
- Date published
- 05/2015
- Academic Unit
- Otolaryngology
- Record Identifier
- 9984966847802771
Metrics
3 Record Views